Search

Jennifer E. Graser

Examiner (ID: 2460)

Most Active Art Unit
1645
Art Unit(s)
1802, 1645, 1641, 1621
Total Applications
1924
Issued Applications
1280
Pending Applications
238
Abandoned Applications
464

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4513546 [patent_doc_number] => 07931908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Chimeric MSP-based malaria vaccine' [patent_app_type] => utility [patent_app_number] => 12/070874 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 20704 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/931/07931908.pdf [firstpage_image] =>[orig_patent_app_number] => 12070874 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/070874
Chimeric MSP-based malaria vaccine Feb 20, 2008 Issued
Array ( [id] => 4872711 [patent_doc_number] => 20080199445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Compositions and methods for treatment of microbial infections' [patent_app_type] => utility [patent_app_number] => 12/069569 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9511 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199445.pdf [firstpage_image] =>[orig_patent_app_number] => 12069569 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/069569
Compositions and methods for treatment of microbial infections Feb 10, 2008 Issued
Array ( [id] => 6071224 [patent_doc_number] => 20110046075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System' [patent_app_type] => utility [patent_app_number] => 12/526222 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15322 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046075.pdf [firstpage_image] =>[orig_patent_app_number] => 12526222 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/526222
Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System Feb 5, 2008 Abandoned
Array ( [id] => 5315958 [patent_doc_number] => 20090280556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Mesothelin, A Differentiation Antigen Present On Mesothelium, Mesotheliomas, and Ovarian Cancers and Methods and Kits for Targeting the Antigen' [patent_app_type] => utility [patent_app_number] => 12/021151 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18373 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280556.pdf [firstpage_image] =>[orig_patent_app_number] => 12021151 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/021151
Mesothelin, A Differentiation Antigen Present On Mesothelium, Mesotheliomas, and Ovarian Cancers and Methods and Kits for Targeting the Antigen Jan 27, 2008 Abandoned
Array ( [id] => 5585031 [patent_doc_number] => 20090104233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'IDENTIFICATION OF RESIDUES CRITICAL FOR THE FUNCTION OF THE VIBRIO CHOLERAE VIRULENCE REGULATOR ToxT BY SCANNING ALANINE MUTAGENESIS' [patent_app_type] => utility [patent_app_number] => 12/020398 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17335 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104233.pdf [firstpage_image] =>[orig_patent_app_number] => 12020398 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/020398
Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis Jan 24, 2008 Issued
Array ( [id] => 4823015 [patent_doc_number] => 20080227706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS' [patent_app_type] => utility [patent_app_number] => 12/018071 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10123 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227706.pdf [firstpage_image] =>[orig_patent_app_number] => 12018071 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/018071
BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS Jan 21, 2008 Abandoned
Array ( [id] => 4675662 [patent_doc_number] => 20080213291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Malaria vaccines' [patent_app_type] => utility [patent_app_number] => 12/006784 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12964 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213291.pdf [firstpage_image] =>[orig_patent_app_number] => 12006784 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/006784
Malaria vaccines Jan 2, 2008 Issued
Array ( [id] => 5374161 [patent_doc_number] => 20090311722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines' [patent_app_type] => utility [patent_app_number] => 11/965004 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10660 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311722.pdf [firstpage_image] =>[orig_patent_app_number] => 11965004 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/965004
Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines Dec 26, 2007 Issued
Array ( [id] => 4839396 [patent_doc_number] => 20080279881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines' [patent_app_type] => utility [patent_app_number] => 11/964982 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11766 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279881.pdf [firstpage_image] =>[orig_patent_app_number] => 11964982 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/964982
Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines Dec 26, 2007 Issued
Array ( [id] => 5580566 [patent_doc_number] => 20090175912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Haemophilus Influenza Outer Membrane Protein and Use Thereof in Vaccination' [patent_app_type] => utility [patent_app_number] => 11/960883 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6572 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175912.pdf [firstpage_image] =>[orig_patent_app_number] => 11960883 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/960883
Haemophilus influenzae outer membrane protein and use thereof in vaccination Dec 19, 2007 Issued
Array ( [id] => 6302374 [patent_doc_number] => 20100068214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus' [patent_app_type] => utility [patent_app_number] => 12/520395 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23663 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068214.pdf [firstpage_image] =>[orig_patent_app_number] => 12520395 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520395
Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus Dec 18, 2007 Abandoned
Array ( [id] => 6423760 [patent_doc_number] => 20100168012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE' [patent_app_type] => utility [patent_app_number] => 12/519362 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23992 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168012.pdf [firstpage_image] =>[orig_patent_app_number] => 12519362 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/519362
HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE Dec 13, 2007 Abandoned
Array ( [id] => 6439549 [patent_doc_number] => 20100279344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Integrated cytokine production system' [patent_app_type] => utility [patent_app_number] => 12/000470 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8436 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279344.pdf [firstpage_image] =>[orig_patent_app_number] => 12000470 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/000470
Integrated cytokine production system Dec 12, 2007 Abandoned
Array ( [id] => 8066081 [patent_doc_number] => 20110243980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHODS AND SYSTEMS FOR O-GLYCOSYLATING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/519085 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9969 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243980.pdf [firstpage_image] =>[orig_patent_app_number] => 12519085 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/519085
Methods and systems for O-glycosylating proteins Dec 12, 2007 Issued
Array ( [id] => 5410073 [patent_doc_number] => 20090123972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Staphylococcal nuclease fusion proteins for the production of recombinant peptides' [patent_app_type] => utility [patent_app_number] => 12/000370 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14428 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123972.pdf [firstpage_image] =>[orig_patent_app_number] => 12000370 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/000370
Staphylococcal nuclease fusion proteins for the production of recombinant peptides Dec 11, 2007 Abandoned
Array ( [id] => 5415909 [patent_doc_number] => 20090041796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Surface protein of leptospira' [patent_app_type] => utility [patent_app_number] => 12/001114 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6926 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041796.pdf [firstpage_image] =>[orig_patent_app_number] => 12001114 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/001114
Surface protein of leptospira Dec 9, 2007 Issued
Array ( [id] => 11136605 [patent_doc_number] => 09372191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Methods and devices for detecting methicillin resistant Staphylococcus aureus' [patent_app_type] => utility [patent_app_number] => 12/517771 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2210 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517771 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/517771
Methods and devices for detecting methicillin resistant Staphylococcus aureus Dec 9, 2007 Issued
Array ( [id] => 6436658 [patent_doc_number] => 20100143936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/520487 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9642 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143936.pdf [firstpage_image] =>[orig_patent_app_number] => 12520487 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/520487
Specific arabinose transporter from the yeast Pichia stipitis, and uses thereof Dec 6, 2007 Issued
Array ( [id] => 4791661 [patent_doc_number] => 20080292634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Nontypable Haemophilus Infuenzae Virulence Factors' [patent_app_type] => utility [patent_app_number] => 11/946563 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13578 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292634.pdf [firstpage_image] =>[orig_patent_app_number] => 11946563 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/946563
Nontypeable Haemophilus influenzae virulence factors Nov 27, 2007 Issued
Array ( [id] => 7527033 [patent_doc_number] => 08043624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Compositions and methods for treatment of microbial infections' [patent_app_type] => utility [patent_app_number] => 11/986715 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043624.pdf [firstpage_image] =>[orig_patent_app_number] => 11986715 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986715
Compositions and methods for treatment of microbial infections Nov 25, 2007 Issued
Menu